Proceedings of the National Academy of Sciences · 2001 · 173 citations · 22 references
Life SciencesEndocrinologyImmunologyAutoimmunityCellular ImmunologyInflammationAutoimmune Disease PathogenesisAutoimmune DiseasesCell-mediated ImmunityDiabetes MellitusHelper T Cell SubsetsT Cell BiologyImmunohistochemical StainingInflammation In Lymphoid OrgansIslet AutoimmunitySpontaneous Disease ModelsT Helper CellsT-cell Immune ResponsesType 1 Diabetes ModelsType 1 Diabetes Pathophysiology
Quantitative and qualitative defects in CD1-restricted natural killer T cells have been reported in several autoimmune-prone strains of mice, including the nonobese diabetic (NOD) mouse. These defects are believed to be associated with the emergence of spontaneous autoimmunity. Here we demonstrate that both CD1d-null NOD and CD1d-null NOD/BDC2.5 T cell receptor transgenic mice have an accelerated onset and increased incidence of diabetes when compared with CD1d(+/-) and CD1d(+/+) littermates. The acceleration of disease did not seem to result from changes in the T helper (Th)1/Th2 balance because lymphocytes purified from lymphoid organs and pancreatic islets of wild-type and CD1d-null mice secreted equivalent amounts of IFN-gamma and IL-4 after stimulation. In contrast, the pancreata of CD1d-null mice harbored significantly higher numbers of activated memory T cells expressing the chemokine receptor CCR4. Notably, the presence of these T cells was associated with immunohistochemical evidence of increased destructive insulitis. Thus, CD1d-restricted T cells are critically important for regulation of the spontaneous disease process in NOD mice.
22
Following a diabetogenic T cell from genesis through pathogenesis
Jonathan D. Katz, Bo Wang, Kathryn Haskins et al. · Cell · 1993 · 693 citations
Life Sciences, Biology, Immunology +12
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
S. Brian Wilson, Sally C. Kent, Kurt T. Patton et al. · Nature · 1998 · 641 citations